SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
Background: Patients with severe and critical COVID-19 frequently exhibit thromboembolic complications, a significant cause of mortality and morbidity. Increased plasma levels of von Willebrand factor (VWF) following SARS-CoV-2 infection have been extensively reported, which links to thrombosis and...
Saved in:
Main Authors: | Quan Zhang, Xiaohu Huang, Hangnoh Lee, Jin-Gu Lee, Szumam Liu, Shiwani Limbu, Malay K. Basu, Joyce van de Leemput, Felice D’Agnillo, Zhe Han, X. Long Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-05-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2475037925002717 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic value of von Willebrand factor in clinical practice
by: K. N. Grigoreva, et al.
Published: (2022-11-01) -
A facial nodular orf infection in an HIV positive patient: Report of a case
by: Sema Aytekin, et al.
Published: (2025-07-01) -
Clinical significance of measuring ADAMTS-13, its inhibitor and von Willebrand factor in obstetric and gynecological practice
by: K. N. Grigoreva, et al.
Published: (2021-03-01) -
Factor fon Willebrand antigen in endothelium functional state assessment in patients with systemic lupus erythematosus
by: M E Zapryagaeva, et al.
Published: (2004-06-01) -
Clinical significance of assessing ADAMTS-13 and von Willebrand factor level in COVID-19 convalescent pregnant women
by: N. R. Gashimova, et al.
Published: (2023-03-01)